Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]    
Revenue $ 210
Operating costs and expenses:    
Inventor royalties, contingent legal fees, litigation and licensing expenses 161
Research and development expenses (including non-cash stock-based compensation expenses of $1,859 and $2,037, respectively) 6,396 4,769
General and administrative expenses (including non-cash stock-based compensation expenses of $2,923 and $2,698, respectively) 7,435 6,291
Total operating costs and expenses 13,831 11,221
Loss from operations (13,831) (11,011)
Interest income 1,133 1,081
Net loss (12,698) (9,930)
Less: Net loss attributable to noncontrolling interest (144) (119)
Net loss attributable to common shareholders $ (12,554) $ (9,811)
Net loss per share:    
Basic $ (0.39) $ (0.32)
Diluted $ (0.39) $ (0.32)
Weighted average common shares outstanding:    
Basic 31,898 30,980
Diluted 31,898 30,980